Hospital in Gurugram launches India’s first centre of excellence for Myeloma & Lymphoma
New Delhi ( Raghwendra Pratap Singh) : A Gurugram hospital on Thursday inaugurated what it described as India’s first Centre of Excellence for Myeloma and Lymphoma, aimed at providing specialised and integrated care for blood-cancer patients.
Fortis Memorial Research Institute (FMRI), Gurugram, said the centre will bring together experts in haematology, haemato-oncology, pathology, genomics, radiation oncology, stem-cell transplantation, cellular therapies and clinical research on a single platform.
According to the hospital, the disease-focussed centre has been established to address the growing complexity of blood-cancer treatment through personalised care pathways, multidisciplinary collaboration and access to advanced diagnostics and therapies.
Dr Rahul Bhargava, Principal Director and Chief, Haematology, Haemato-Oncology and Bone Marrow Transplant at FMRI, said the initiative seeks to create an ecosystem where scientific discoveries can be translated into personalised treatment strategies for patients.
The centre brings together expertise across genomics, genetics, pathology, translational science, haematology, radiation oncology, cellular therapy, CAR-T and clinical research, giving patients access to advanced diagnostics, therapies and clinical innovations,” he said.
